Patients with early-stage, node-negative, hormone receptor (HR)-positive, HER2- negative breast cancer who have a high risk of recurrence based on the OncotypeDX genomic test had better outcomes when treated with adjuvant anthracycline- plus taxane-based chemotherapy regimens compared with those receiving adjuvant taxane-based chemotherapy regimens alone, according to results presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024.
Study: Firearm injury prevention policies need to be implemented properly to be effective
When evidence-based firearm injury prevention policies such as extreme risk protection orders are implemented properly, they can play a significant role in preventing gun-related injuries
August 14, 2023